YF-VAX 1 dose vials
Ended Awarded Last action
- Contract number
- SPE2DR26FGVD4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,889
Award facts
- Contract value 100% obligated
- $1,888.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,888.62 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. The delivery order, issued on January 6, 2026, with an ultimate completion date of January 28, 2026, carries a firm fixed price and was awarded without a set-aside designation. This award reflects DMS Pharmaceutical Group's competitive capability to win unrestricted federal procurement opportunities despite its small business classification.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion acquisition strategy establishing multiple regional prime vendor contractors. The parent IDC, valued at $499 million with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for a comprehensive range of pharmaceutical products to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group's established performance across numerous delivery orders for diverse pharmaceutical categories, including vaccines, biologics, and specialty medications, demonstrates its capability to serve as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FGVD4?
SPE2DR26FGVD4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FGVD4 worth?
The government has obligated $1,889 on SPE2DR26FGVD4.
Is contract SPE2DR26FGVD4 an order under another contract?
Yes. SPE2DR26FGVD4 is a delivery order under SPE2DR25D9761, an indefinite delivery contract.
Was contract SPE2DR26FGVD4 competed?
The extent of competition for SPE2DR26FGVD4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award